Government of India and World Bank officials. Credit: World Bank.

The Government of India has entered a $125m agreement with the World Bank to advance the country’s biopharmaceutical and medical devices industry.

The partners will focus on the development of technology to drive affordable healthcare in the country as part of the Innovate in India for Inclusiveness Project,

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The project will complement India’s Biotechnology Industry Research Assistance Program (BIRAC) established to form strategic partnerships with innovative start-ups and other companies.

It will work to enable more collaborative research and development (R&D) and harness the expertise of local and international organisations from both the public and private sectors.

“This landmark collaboration between the Department of Biotechnology and World Bank will further catalyse this ecosystem to develop new vaccines, diagnostics and core R&D technologies.”

BIRAC will allow the continuous development of a pipeline of health care products to make the country a ‘low-cost healthcare provider’ and help India’s biopharmaceutical and medical devices industry compete internationally.

Department of Biotechnology secretary Renu Swarup said: “This landmark collaboration between the Department of Biotechnology and World Bank will further catalyse this ecosystem to develop new vaccines, diagnostics and core R&D technologies of medical technology devices while strengthening the existing infrastructure and building collaborative partnerships in parallel.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The latest collaboration will boost technical skills, offer shared facilities for companies carrying out clinical validation, and facilitate the use of new technologies and licensing models from across the globe.

It will also match clinical trial sites with advisor networks and international organisations and support academia, start-ups, and small and medium enterprises by strengthening their research capabilities to develop affordable healthcare products.